Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rami Owera"'
Autor:
Rami Owera, Roger M. Lyons, Sudhir Manda, Philip Twumasi-Ankrah, Kimberly Bogard, Yikun Guo, Presley Whidden, Stephen J. Noga, Ruemu Ejedafeta Birhiray, Saulius Girnius, Leon Bernal-Mizrachi, Habte A. Yimer, Robert M. Rifkin
Publikováno v:
Blood. 138:2726-2726
Background: Use of long-term PI-based therapy can improve outcomes across treatment settings in MM. However, there are various physical, geographical, and/or socioeconomic barriers to prolonged therapy with parenteral PIs in community practice. The U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7404e3805b864181b11ebd1eb298badb
https://doi.org/10.1182/blood-2021-150094
https://doi.org/10.1182/blood-2021-150094
Autor:
Rami Owera, Howard A. Burris, Mathew John Joseph, Ruth E. Lamar, David R. Spigel, Johanna C. Bendell, Cassie M. Lane, D. S. Thompson, Chris Earwood, William Penley, Todd M. Bauer
Publikováno v:
Cancer Investigation. 34:265-270
AUY922 is an inhibitor of heat shock protein 90 (Hsp90). Hsp90 inhibitors induce kit degradation in preclinical gastrointestinal stromal tumor (GIST) models. This trial was designed to determine the progression-free survival (PFS) of patients with GI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a09afdb1c50d9eff792e7466b133bfb
https://doi.org/10.1080/07357907.2016.1193746
https://doi.org/10.1080/07357907.2016.1193746
Autor:
Ian W. Flinn, Jesus G. Berdeja, Lowell L. Hart, Joseph R. Mace, Rami Owera, John D. Hainsworth, Edward Arrowsmith, James Essell
Publikováno v:
Haematologica. 100(5)
The purpose of this study was to assess the safety and efficacy of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma. Patients with multiple myeloma who had relapsed after at least one prior treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0c2fcb6418392592fd71f3353dfcd0a
https://pubmed.ncbi.nlm.nih.gov/25710456
https://pubmed.ncbi.nlm.nih.gov/25710456
Autor:
Lowell L. Hart, Rami Owera, Jeffrey Matous, Edward A. Faber, Tara K. Gregory, James Essell, Jesus G. Berdeja, Ian W. Flinn, Joseph R. Mace
Publikováno v:
Journal of Clinical Oncology. 33:8513-8513
8513 Background: Histone deacetylase inhibitors (HDACi) and proteasome inhibitors (PI) act synergistically through inhibition of the proteasome and aggresome pathways. We have previously reported t...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ade03ea06f85f7b10a84c01b5d29dae
https://doi.org/10.1200/jco.2015.33.15_suppl.8513
https://doi.org/10.1200/jco.2015.33.15_suppl.8513